Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamdy A Azim

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Breast (Edinburgh, Scotland)|February 15, 2011
Survey of utilization of multidisciplinary management tumor boards in Arab countriesNagi S El Saghir, Nadine El-Asmar, Carla Hajj, et al.
Ecancermedicalscience|December 11, 2013
One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignanciesHamdy A Azim, Sherif Ahmed Bahr, Nermine Shawky Kamal, et al.
Breast Cancer Research and Treatment|October 9, 2021
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populationMichelino De Laurentiis, Simona Borstnar, Mario Campone, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa regionAli Bazarbachi, Hamdy A Azim, Hussain Alizadeh, et al.
Breast Cancer Research and Treatment|August 20, 2021
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populationMichelino De Laurentiis, Simona Borstnar, Mario Campone, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohortRasha Aboelhassan, Mohamed Emam Sobeih, Mohamed Alm El-Din, et al.
Cancers|June 2, 2021
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast CancerHesham Elghazaly, Hope S Rugo, Hamdy A Azim, et al.
Cancer|July 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendationsHesham Elghazaly, Hamdy A Azim, Hope S Rugo, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Breast (Edinburgh, Scotland)|February 15, 2011
Survey of utilization of multidisciplinary management tumor boards in Arab countriesNagi S El Saghir, Nadine El-Asmar, Carla Hajj, et al.
Ecancermedicalscience|December 11, 2013
One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignanciesHamdy A Azim, Sherif Ahmed Bahr, Nermine Shawky Kamal, et al.
Breast Cancer Research and Treatment|October 9, 2021
Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populationMichelino De Laurentiis, Simona Borstnar, Mario Campone, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa regionAli Bazarbachi, Hamdy A Azim, Hussain Alizadeh, et al.
Breast Cancer Research and Treatment|August 20, 2021
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populationMichelino De Laurentiis, Simona Borstnar, Mario Campone, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
Real-world treatment patterns and clinical outcomes in patients with stage III non-small cell lung cancer: results of KINDLE-Egypt cohortRasha Aboelhassan, Mohamed Emam Sobeih, Mohamed Alm El-Din, et al.
Cancers|June 2, 2021
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast CancerHesham Elghazaly, Hope S Rugo, Hamdy A Azim, et al.
Cancer|July 10, 2024
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendationsHesham Elghazaly, Hamdy A Azim, Hope S Rugo, et al.
Pageof 4